Table 1 Demographic and clinical characteristics of subjects
From: Abnormalities of age-related T cell senescence in Parkinson’s disease
Variable | PD (n = 41) | Controls (n = 41) | p |
|---|---|---|---|
Age (years) | 68.4 (6.3) | 68.1 (5.6) | 0.85 |
Gender (% male) | 68.3 | 68.3 | 1.0 |
Disease duration (years) | 4.3 (1.2) | ||
MDS-UPDRS motor score | 34.9 (12.4) | ||
ACE-R | 93.0 (8.3) | ||
Levodopa equivalent daily dose (mg) | 591.5 (292.9) | ||
CMV IgG (% positive) | 46.3 | 61.0 | 0.18 |